Evidence map›Paper›PMID 27443140›Full record

ReviewCardiology clinics2016

Group 5 Pulmonary Hypertension: The Orphan's Orphan Disease.

Sara Kalantari, Mardi Gomberg-Maitland

Abstract readReview
In one paragraph

Review in Cardiology clinics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Clinical Updates in Pulmonary Hypertension.Reviews in cardiovascular medicine · 2026
    Review
  5. Journal of preventive medicine and hygiene · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances.American journal of respiratory and critical care medicine · 2021
    Article
  13. Diagnosis and Management of Pulmonary Hypertension in Patients With CKD.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2020
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sara KalantariSection of Cardiology, Department of Medicine, University of Chicago Medical Center, 5841 South Maryland Avenue, MC 5403, Chicago, IL 60637, USA.
Mardi Gomberg-MaitlandSection of Cardiology, Department of Medicine, University of Chicago Medical Center, 5841 South Maryland Avenue, MC 5403, Chicago, IL 60637, USA; Pulmonary Hypertension Program, Cardiovascular Division, University of Chicago Medical Center, 5841 South Maryland Avenue, MC 5403, Chicago, IL 60637, USA. Electronic address: mgomberg@bsd.uchicago.edu.

Funding

MULTIDISCIPLINARY CARDIAC SCIENCEST32HL007381 · NHLBI · UNIVERSITY OF CHICAGO · PI JEANNE M DECARA, Yoav Gilad · 1985 to 2026
$12.5M
NHLBI NIH HHS T32 HL007381
6 · The paper itself

Abstract

Pulmonary hypertension is a complex disorder with multiple etiologies; the World Health Organization classification system divides pulmonary hypertension patients into 5 groups based on the underlying cause and mechanism. Group 5 pulmonary hypertension is a heterogeneous group of diseases that encompasses pulmonary hypertension secondary to multifactorial mechanisms. For many of the diseases, the true incidence, etiology, and treatment remain uncertain. This article reviews the epidemiology, pathogenesis, and management of many of the group 5 pulmonary hypertension disease states.

Indexed as

Hypertension, PulmonaryRare DiseasesGlobal HealthHumansIncidencePrevalencePulmonary Wedge PressureChronic thromboembolic pulmonary hypertensionMultifactorialPulmonary hypertension

Identifiers

PMID27443140
PMCPMC5391979

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.